Relationship between Serum Bilirubin Levels and Metabolic Syndrome in Patients with Schizophrenia Spectrum Disorders

Karadag, RUKİYE; Sengul, Ceyhan; ENLİ, YAŞAR; Karakulah, Kamuran; Alacam, Huseyin; Kaptanoglu, Bunyamin; Kalkanci, Ozgur; Herken, Hasan

doi:10.9758/cpn.2017.15.2.153

Relationship between Serum Bilirubin Levels and Metabolic Syndrome in Patients with Schizophrenia Spectrum Disorders

Atıf İçin Kopyala

Karadag F., Sengul C. B., ENLİ Y., Karakulah K., Alacam H., Kaptanoglu B., ...Daha Fazla

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, cilt.15, sa.2, ss.153-162, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 15 Sayı: 2
Basım Tarihi: 2017
Doi Numarası: 10.9758/cpn.2017.15.2.153
Dergi Adı: CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.153-162
Anahtar Kelimeler: Schizophrenia, Metabolic syndrome, Bilirubin, Atypical antipsychotics, INVERSE RELATIONSHIP, INSULIN-RESISTANCE, HEART-DISEASE, RISK, ASSOCIATION, PREVALENCE, ADULTS, MEN
Gazi Üniversitesi Adresli: Evet

Özet

Objective: We investigated the relationship between serum bilirubin levels and metabolic syndrome (MetS), and the longitudinal effects of baseline serum bilirubin concentrations on MetS in patients with schizophrenia spectrum disorders undergoing atypical antipsychotics.